Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease, and their changes after l-dopa administration-Reference-Cited by-同舟云学术

Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease, and their changes after l-dopa administration

Published:1993-09 Issue:1-2 Volume:159 Page:135-138
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Tohgi Hideo,Abe Takashi,Takahashi Satoshi,Takahashi Junko,Hamato Humitoshi

Publisher

Elsevier BV

Subject

General Neuroscience

Reference20 articles.

1. Biochemistry of neurotransmitters in Parkinson's disease;Agid,1987

2. Verteilung des 5-Hydroxytryptamins (Serotonin) im Gehirn des Menschen und sein Verhalten bei Patienten mit Parkinson-Syndrom;Bernheimer;Klin. Wochenschr.,1961

3. Depletion of 5-HT by l-dopa in spinal cord and brainstem of rat;Commissiong;Life Sci.,1979

4. Levodopa: effect on concentration of dopamine, norepinephrine, and serotonin in brains of mice;Everett;Science,1970

5. Mini-Mental State;Folstein;J. Psychiatr. Res.,1975

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with Neurodegenerative Proteinopathies Exhibit Altered Tryptophan Metabolism in the Serum and Cerebrospinal Fluid;ACS Chemical Neuroscience;2024-01-09

2. Dynamic changes in metabolites of the kynurenine pathway in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: A systematic Review and meta-analysis;Frontiers in Immunology;2022-10-03

3. Cerebrospinal and blood levels of amino acids as potential biomarkers for Parkinson’s disease: review and meta‐analysis;European Journal of Neurology;2020-09-11

4. Impaired metabolism of kynurenine and its metabolites in CSF of parkinson’s disease;Neuroscience Letters;2020-01

5. Dalfampridine in Parkinson's disease related gait dysfunction: A randomized double blind trial;Journal of the Neurological Sciences;2017-08